Current Firm
Compound
Focus
AI, Biotech
Shelby Newsad is an investor at Compound, a venture capital firm focused on identifying and supporting transformative technologies. With expertise spanning AI, biotech, Web3, robotics, and deeptech, Shelby brings a diversified investment perspective to emerging innovation sectors. At Compound, Shelby evaluates opportunities at the intersection of cutting-edge technology and market potential, supporting founders building the next generation of breakthrough companies. Their investment thesis centers on technologies with the capacity to create significant impact across multiple industries, from artificial intelligence and biological sciences to decentralized systems and advanced robotics. Shelby's multidisciplinary focus reflects a commitment to backing visionary entrepreneurs pushing the boundaries of what's possible in deeptech and emerging fields.
Shelby Newsad is a Investor, Compound at Compound, based in San Francisco, CA.
Shelby's investment focus spans AI, Biotech, Web3, Robotics, Deeptech, primarily investing at the Seed, Series A stages. This specialization allows for deep domain knowledge and strong network effects that benefit portfolio companies.
Shelby Newsad is a Investor, Compound at Compound, based in San Francisco, CA. Their investment focus includes AI, Biotech, Web3.
Shelby Newsad focuses on investments in AI, Biotech, Web3, Robotics, Deeptech through Compound. These focus areas reflect their domain expertise and the types of startups they actively seek to back.
Shelby Newsad is currently at Compound, headquartered in San Francisco, CA, serving as Investor, Compound.